AAEON's GENE-APL7 Subcompact Board Deployed for Medical Research
April 23, 2020
AAEON's GENE-APL7 3.5" Subcompact board is deployed in medical research to develop treatments and vaccines for the ongoing COVID-19 pandemic.
Due to the increasing cases of COVID-19, biotech developers are deploying blood and virus testing devices to help. Many of these machines are powered by the GENE-APL7 subcompact board, featuring Intel processors, from AAEON to provide accurate results for medical researchers.
The GENE-APL7 3.5"" subcompact board is small in size, making it ideal for fitting into medical equipment. The GENE-APL7 can be expanded to support up to 10 USB ports and 11 COM ports, allowing it to interface with multiple testing devices to provide sample analysis.
The GENE-APL7 can be embedded into machines with fanless operation. The GENE-APL7 supports multiple video outputs including eDP and VGA with support for 4K HD.
The GENE-APL7 is deployed to many applications within the medical field, including hospital telemedicine equipment, and in US pharmacies for applications including customer data management and real-time sharing of medical records.
For more information, please visit www.aaeon.com